Does Reinfusion of Stem Cell Products on Multiple Days Affect Engraftment?

OBJECTIVE: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x10(6)/kg CD34+ cells is preferred to achieve engraftment. Some patients need multiple leukapheresis procedures...

Descripción completa

Detalles Bibliográficos
Autores principales: Solmaz Medeni, Şerife, Türkyılmaz, Doğuş, Acar, Celal, Sevindik, Ömür Gökmen, Yüksel, Faize, Pişkin, Özden, Özcan, Mehmet Ali, Demirkan, Fatih, Ündar, Bülent, Alacacıoğlu, İnci, Özsan, Güner Hayri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256826/
https://www.ncbi.nlm.nih.gov/pubmed/29923493
http://dx.doi.org/10.4274/tjh.2018.0071

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256826/
https://www.ncbi.nlm.nih.gov/pubmed/29923493
http://dx.doi.org/10.4274/tjh.2018.0071

Ejemplares similares